Table 2.
Scrapie strain | Original strain isolated in tg338 mice | Drosophila-passaged strain isolated in tg338 mice | ||||
---|---|---|---|---|---|---|
First passage | Second passage | |||||
Attack rate | IP | Attack rate | IP | Attack rate | IP | |
PG127 | 6/6 | 61 ± 2 | 6/6 | 87 ± 4 | 6/6 | 59 ± 1 |
Pa59 | 6/6 | 143 ± 3 | 6/6 | 187 ± 4 | 6/6 | 142 ± 1 |
Apl338 | 6/6 | 631 ± 83 | 3/5 | 642 ± 57 | NA | NA |
The ovine classical scrapie prion strains PG127 and Apl338 (isolated in ovine VRQ tg338 mice) and Pa59 (isolated in ovine ARQ tg59 mice) were transmitted to tg338 ovine PrP transgenic mice. The ovine classical scrapie prion strains PG127, Pa59 or Apl338 were transmitted to tg338 ovine PrP transgenic mice. In parallel, Actin × VRQ(GPI) PrP transgenic (VRQ) Drosophila were exposed to the PG127 and Apl338, prion strains, and Elav × ARQ(GPI) PrP transgenic (ARQ) Drosophila were exposed to the Pa59 prion strain, at the larval stage. Head homogenates were prepared from adult flies aged 30 days and serially transmitted in tg338 mice (two iterative passages) by intracerebral inoculation. Mice were euthanized when they showed clinical signs of prion infection and after 250 days for those that did not develop clinical disease. Mice were considered positive for prion disease when PK-resistant PrP27–30 was detected in brain tissue by western blot. The attack rate (number of prion positive mice/total number of mice inoculated) is reported for each treatment group. The incubation period (IP) for inoculated mice, which represents the mean time from inoculation to euthanasia for each inoculated group of animals, is reported in days ± SD. NA = data not available, still ongoing.